US-based NuSil Technology, a leading formulator and manufacturer of silicone compounds for the healthcare and pharmaceutical industries, has completed the construction of 2,400ft2 of controlled manufacturing facilities that are environmentally controlled up to Class 10,000.
In recent years NuSil has seen an increase in demand from manufacturers of controlled release and combination products for the compounding and delivery of silicones that contain APIs.
“In the last several years, we’ve seen an increase in demand from manufacturers of controlled release and combination products to compound and deliver silicones that contain APIs,” said Brian Reilly, NuSil Technology’s product director for healthcare materials.
“As a direct result of that spike in interest, we felt it was time to make a capital investment in multiple facility expansions that would ensure all future compounding was done in a safe and controlled environment.”
NuSil recently launched a comprehensive Drug Delivery Silicone (DDS) line of materials and services intended specifically for drug delivery and combination medical device products. The new and much larger facilities are a natural addition created to meet the healthcare industry's rapidly increasing need for a silicone manufacturer capable of compounding an API into silicone.
Featuring state-of-the-art equipment, the facilities process a wide variety of silicones with a range of consistencies. The new clean rooms are registered with the US FDA, as well as the California State Health Department.
Contact T +1 805 684 8780 www.nusil.com/products/healthcare
